Ann: PD-1 cancer vaccine development update, page-22

when you have 50,60, 100, half a billion dollars invested into companies that either are in combo with Keyrtuda or in competition to the Keytruda (and/or combo therapy) market the large pharmas can't afford to have other drugs sitting around in competition

I'm only commenting from the commercial aspect in my posts

however from VLA I'm across the combo trials and the basics of how it works etc unless its very different for IMU

Paul Hopper still here nothing changed on that front he's the man to do the magic after all